Britain s Oxford University said on Friday its researchers behind the joint AstraZeneca Covid-19 vaccine had found it to be effective against the UK virus variant now dominant across the country. The university, which developed the jab with the British-Swedish pharmaceutical firm, said an ongoing assessment of its effectiveness showed that it has
AstraZeneca vaccine effective against UK variant: Oxford University
Published On
AstraZeneca vaccine effective against UK variant: Oxford University
LONDON (AFP) - Britain’s Oxford University said on Friday its researchers behind the joint AstraZeneca Covid-19 vaccine had found it to be effective against the UK virus variant now dominant across the country.
The university, which developed the jab with the British-Swedish pharmaceutical firm, said an ongoing assessment of its effectiveness showed that it has similar efficacy to other coronavirus strains. Data from our trials. in the United Kingdom indicate that the vaccine not only protects against the original pandemic virus, but also protects against the novel variant, said Andrew Pollard, co-chief investigator on the Oxford vaccine trial.
Welcome to Morningstar.co.uk!
You have been redirected here from Hemscott.com as we are merging our websites to provide you with a one-stop shop for all your investment research needs.
Get Started: To search for a security, type the name or ticker in the search box at the top of the page and select from the dropdown results.
Registered Hemscott users can log in to Morningstar using the same login details. Similarly, if you are a Hemscott Premium user, you now have a Morningstar Premium account which you can access using the same login details.